Form 4 for BSX Boston Scientific
Accepted 2021-07-27 00:00:00 ET · period of report 2021-07-27 · accession 0001225208-21-010899 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-27 | 2021-07-27 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $45.22 | -6,748 | 133.1K | -5% | -$305.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-27 | S | D | 6,748 | $45.22 | 133,118 | D | — | — | (F2) Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. |